Live Chart

O 344.9

H 344.9

L 344.9

VOL 3894

Granules India Overview

Days Range

Low: ₹343.00
High: ₹356.00
Previous Close ₹341.85
Open ₹344.90
Volume 23,85,607
Day’s Range ₹343.00 - ₹356.00
52W Range ₹267.75 - ₹381.00
Market Cap ₹8,268.18 Cr

Fundamentals of Granules India

ROCE (TTM) 18.71%
P/E Ratio (TTM) 18.93
P/B Ratio 2.92
Industry P/E 31.91
Debt to Equity 0.4
ROE 18.22%
EPS (TTM) 18.05
Dividend Yield 0.44%
Book Value 117
Face Value 1

Financials of Granules India

Sep 2022Dec 2022Mar 2023Jun 2023
Net Sales1,150.731,146.131,195.5985.52
Profit before tax190.41166.9163.9965.47
Operating Profit145.1124.33119.6147.9
Net Profit145.1124.33119.6147.9
EPS in Rs5.855.114.941.98

About Granules India

Granules India Limited is a large-scale vertically integrated company founded in March 18th, 1991 manufacturing Active Pharmaceutical Ingredient (API), Pharmaceutical Formulation Intermediate (PFI) an ... Read More

Parent Organisation Indian Private
Founded 1991
Managing Director C Krishna Prasad

Peer Comparison

Stocks Market Cap (cr) Market Price (₹) 52 Week Low-High (₹)
Supriya Lifescience Ltd ₹2,227.76


4.70 (1.70%)

274.7 - 286
Celestial Biolabs Ltd ₹4.56


0.00 (0.00)

1.75 - 1.8
JFL Life Sciences Ltd ₹48.45


2.85 (6.47%)

44.1 - 46.9
Procter & Gamble Health Ltd ₹8,490.07


2.80 (0.05%)

5064.65 - 5135.7
Veerhealth Care Ltd ₹40.84


0.00 (0.00)

26 - 26

What's Trending


What is the Share price of Granules India (GRANULES)?

Granules India (GRANULES) share price as of September 29, 2023, on NSE is Rs 354.75 (NSE) and Rs 354.75 (BSE) on BSE.

Can I buy Granules India (GRANULES) shares?

Yes, You can buy Granules India (GRANULES) shares by opening a Demat account with Angel One.

How do I buy Granules India (GRANULES) from Angel One?

Granules India (GRANULES) share can be brought through the following modes:
  1. Direct investment: You can buy Granules India (GRANULES) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Granules India (GRANULES) shares.

Is Granules India a Debt free Company?

No, Granules India is not a debt free company.

What is the main business of Granules India?

The main business of Granules India is to produce and sell several high-quality pharmaceutical products, such as Active Pharmaceutical Ingredients (API), Finished doses (FD), and Pharmaceutical Formulation Intermediates (PFI) across India, North America, Europe, and Latin America.

Who are the promoters of Granules India?

Some of the top promoters of Granules India are Krishna Prasad Chigurupati, Chigurupati Uma Devi, Tyche Investments Private Imited, Pragnya Chigurupati, Chigurupati Priyanka, Santhi Sree Ramanavarapu, Suseela Devi Chigurupati, Nikhila Reddy Yedaguri, Harsha Chigurupati, and Venkata Mahesh Krishna Narra.

What are the Subsidiaries that comes under Granules India?

Some of the wholly owned subsidiaries that come under Granules India are Granules USA, Inc., Granules Pharmaceuticals, Inc., Granules Europe Limited, and Granules Life Sciences Private Limited.